annual CFI:
$363.44M+$123.87M(+51.70%)Summary
- As of today (May 27, 2025), AGIO annual cash flow from investing activities is $363.44 million, with the most recent change of +$123.87 million (+51.70%) on December 31, 2024.
- During the last 3 years, AGIO annual CFI has fallen by -$885.34 million (-70.90%).
- AGIO annual CFI is now -70.90% below its all-time high of $1.25 billion, reached on December 31, 2021.
Performance
AGIO Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$112.59M+$161.75M(+329.03%)Summary
- As of today (May 27, 2025), AGIO quarterly cash flow from investing activities is $112.59 million, with the most recent change of +$161.75 million (+329.03%) on March 31, 2025.
- Over the past year, AGIO quarterly CFI has dropped by -$11.97 million (-9.61%).
- AGIO quarterly CFI is now -93.99% below its all-time high of $1.87 billion, reached on March 31, 2021.
Performance
AGIO quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$351.47M-$11.97M(-3.29%)Summary
- As of today (May 27, 2025), AGIO TTM cash flow from investing activities is $351.47 million, with the most recent change of -$11.97 million (-3.29%) on March 31, 2025.
- Over the past year, AGIO TTM CFI has increased by +$44.92 million (+14.66%).
- AGIO TTM CFI is now -80.92% below its all-time high of $1.84 billion, reached on March 31, 2021.
Performance
AGIO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
AGIO Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.7% | -9.6% | +14.7% |
| 3 y3 years | -70.9% | +523.7% | +153.9% |
| 5 y5 years | +297.5% | +4.1% | +415.2% |
AGIO Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -70.9% | +51.7% | -55.1% | +329.0% | -30.8% | +153.9% |
| 5 y | 5-year | -70.9% | +379.8% | -94.0% | +137.8% | -80.9% | +153.9% |
| alltime | all time | -70.9% | +209.0% | -94.0% | +137.8% | -80.9% | +153.9% |
AGIO Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $112.59M(-329.0%) | $351.47M(-3.3%) |
| Dec 2024 | $363.44M(+51.7%) | -$49.16M(-119.6%) | $363.44M(-28.5%) |
| Sep 2024 | - | $250.79M(+573.4%) | $508.11M(+71.3%) |
| Jun 2024 | - | $37.24M(-70.1%) | $296.66M(-3.2%) |
| Mar 2024 | - | $124.56M(+30.4%) | $306.54M(+28.0%) |
| Dec 2023 | $239.57M(-1.5%) | $95.51M(+142.8%) | $239.57M(+5.5%) |
| Sep 2023 | - | $39.34M(-16.5%) | $227.01M(-22.2%) |
| Jun 2023 | - | $47.13M(-18.2%) | $291.74M(-10.9%) |
| Mar 2023 | - | $57.60M(-30.6%) | $327.43M(+34.6%) |
| Dec 2022 | $243.26M(-80.5%) | $82.95M(-20.3%) | $243.26M(+269.2%) |
| Sep 2022 | - | $104.07M(+25.7%) | $65.89M(-124.3%) |
| Jun 2022 | - | $82.81M(-411.6%) | -$270.91M(-58.4%) |
| Mar 2022 | - | -$26.57M(-71.9%) | -$651.87M(-152.2%) |
| Dec 2021 | $1.25B(+1548.6%) | -$94.42M(-59.4%) | $1.25B(-11.7%) |
| Sep 2021 | - | -$232.73M(-21.9%) | $1.41B(-7.0%) |
| Jun 2021 | - | -$298.15M(-115.9%) | $1.52B(-17.4%) |
| Mar 2021 | - | $1.87B(+2524.9%) | $1.84B(+2331.4%) |
| Dec 2020 | $75.75M(-17.2%) | $71.40M(-156.6%) | $75.75M(-142.0%) |
| Sep 2020 | - | -$126.24M(-662.1%) | -$180.42M(-788.6%) |
| Jun 2020 | - | $22.46M(-79.2%) | $26.20M(-61.6%) |
| Mar 2020 | - | $108.14M(-158.5%) | $68.22M(-25.4%) |
| Dec 2019 | $91.44M(-133.4%) | -$184.77M(-329.9%) | $91.44M(-65.3%) |
| Sep 2019 | - | $80.38M(+24.7%) | $263.41M(+41.8%) |
| Jun 2019 | - | $64.48M(-50.9%) | $185.80M(+641.4%) |
| Mar 2019 | - | $131.35M(-1125.8%) | $25.06M(-109.2%) |
| Dec 2018 | -$273.82M | -$12.80M(-562.1%) | -$273.82M(+24.9%) |
| Sep 2018 | - | $2.77M(-102.9%) | -$219.17M(+40.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$96.26M(-42.5%) | -$155.53M(-53.6%) |
| Mar 2018 | - | -$167.53M(-500.3%) | -$334.99M(+478.5%) |
| Dec 2017 | -$57.91M(-51.5%) | $41.85M(-37.0%) | -$57.91M(-67.3%) |
| Sep 2017 | - | $66.42M(-124.1%) | -$177.27M(-42.1%) |
| Jun 2017 | - | -$275.73M(-351.7%) | -$306.44M(-6192.1%) |
| Mar 2017 | - | $109.55M(-241.3%) | $5.03M(-104.2%) |
| Dec 2016 | -$119.35M(-193.0%) | -$77.52M(+23.5%) | -$119.35M(+471.8%) |
| Sep 2016 | - | -$62.74M(-275.6%) | -$20.87M(-129.0%) |
| Jun 2016 | - | $35.74M(-341.0%) | $72.03M(+5.2%) |
| Mar 2016 | - | -$14.83M(-170.8%) | $68.49M(-46.6%) |
| Dec 2015 | $128.31M(-138.5%) | $20.96M(-30.5%) | $128.31M(-171.3%) |
| Sep 2015 | - | $30.16M(-6.4%) | -$179.95M(-20.1%) |
| Jun 2015 | - | $32.21M(-28.4%) | -$225.21M(-18.4%) |
| Mar 2015 | - | $44.99M(-115.7%) | -$276.08M(-17.2%) |
| Dec 2014 | -$333.34M(+282.2%) | -$287.30M(+1802.9%) | -$333.34M(+401.7%) |
| Sep 2014 | - | -$15.10M(-19.1%) | -$66.44M(-49.7%) |
| Jun 2014 | - | -$18.67M(+52.2%) | -$132.07M(+27.6%) |
| Mar 2014 | - | -$12.27M(-39.9%) | -$103.52M(+18.7%) |
| Dec 2013 | -$87.22M(-478.5%) | -$20.41M(-74.7%) | -$87.22M(+85.7%) |
| Sep 2013 | - | -$80.72M(-917.1%) | -$46.97M(-246.6%) |
| Jun 2013 | - | $9.88M(+144.8%) | $32.03M(+91.9%) |
| Mar 2013 | - | $4.04M(-79.7%) | $16.69M(-27.6%) |
| Dec 2012 | $23.04M(-203.1%) | $19.84M(-1252.0%) | $23.04M(+618.9%) |
| Sep 2012 | - | -$1.72M(-68.5%) | $3.21M(-35.0%) |
| Jun 2012 | - | -$5.46M(-152.6%) | $4.93M(-52.6%) |
| Mar 2012 | - | $10.39M | $10.39M |
| Dec 2011 | -$22.36M | - | - |
FAQ
- What is Agios Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual CFI year-on-year change?
- What is Agios Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly CFI year-on-year change?
- What is Agios Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals TTM CFI year-on-year change?
What is Agios Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of AGIO is $363.44M
What is the all time high annual CFI for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual cash flow from investing activities is $1.25B
What is Agios Pharmaceuticals annual CFI year-on-year change?
Over the past year, AGIO annual cash flow from investing activities has changed by +$123.87M (+51.70%)
What is Agios Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of AGIO is $112.59M
What is the all time high quarterly CFI for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly cash flow from investing activities is $1.87B
What is Agios Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, AGIO quarterly cash flow from investing activities has changed by -$11.97M (-9.61%)
What is Agios Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of AGIO is $351.47M
What is the all time high TTM CFI for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high TTM cash flow from investing activities is $1.84B
What is Agios Pharmaceuticals TTM CFI year-on-year change?
Over the past year, AGIO TTM cash flow from investing activities has changed by +$44.92M (+14.66%)